ABSTRACT
The therapeutic efficacy of duspatalin was evaluated in 72 patients with chronic cholecystitis and dyskinesia of the biliary tract (BT). Supplementation of duspatalin to the combined therapy in the patients with chronic cholecystitis shown to exert a pronounced therapeutic effect. This caused positive changes in clinical symptoms and BT function and quality of life, diminished the lithogenic properties of bile.
Subject(s)
Acalculous Cholecystitis/drug therapy , Parasympatholytics/therapeutic use , Phenethylamines/therapeutic use , Acalculous Cholecystitis/diagnosis , Acalculous Cholecystitis/psychology , Adolescent , Adult , Attitude to Health , Chronic Disease , Humans , Parasympatholytics/administration & dosage , Phenethylamines/administration & dosage , Quality of Life , Treatment Outcome , Young AdultABSTRACT
The therapeutic efficacy of duspatalin was evaluated in 69 patients with chronic cholecystitis and dyskinesia of the biliary tract (BT). Supplementation of duspatalin to the combined therapy in the patients with chronic cholecystitis shown to exert a pronounced therapeutic effect. This caused positive changes in clinical symptoms and BT function and quality of life, diminished the lithogenic properties of bile.
